Ask AI
HBV Innovations

CE / CME

Beyond the Status Quo: Exploring the Future Impact of HBV Innovations

Pharmacists: 1.50 contact hours (0.15 CEUs)

Nurse Practitioners/Nurses: 1.50 Nursing contact hours

Physicians: maximum of 1.50 AMA PRA Category 1 Credits

Released: November 20, 2025

Expiration: November 19, 2026

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

Evidence suggests that, in most people with CHB, nucleos(t)ide analogues are associated with:

2.

Your patient with HBeAg-negative CHB has a qHBsAg result of 50 IU/mL. What can you tell them about this result?

3.

Evidence suggests that, in most cases, capsid assembly modulators for CHB treatment are associated with: